The Trump administration will require all 50 states to explain their plans to revalidate some of their Medicaid providers in ...
The Trump administration had planned for insurers to provide cheap weight loss drugs to seniors through a Medicare pilot ...
Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
CMS pauses weight-loss BALANCE model for Medicare Part D after insufficient plan sponsor participation, while Medicaid pilot continues.
Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.
In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...
The Trump administration has extended a short-term program that offers Medicare coverage for weight loss drugs such as Novo’s (NVO) Wegovy and Lilly’s (LLY) Zepbound after leading health insurers ...
CMS pitches hospital pay with a 2.4% increase and launches a mandatory joint replacement payment model starting fiscal year 2027.
Agency plans to ask states to "own" the problem of healthcare fraud ...